Christine Strand
About Christine Strand
Christine Strand is a scientist at Bristol Myers Squibb in Cambridge, Massachusetts, with a background in biochemistry and extensive experience in early target biology, genetic perturbation, and clinical research.
Current Position at Bristol Myers Squibb
Christine Strand currently holds the position of Scientist at Bristol Myers Squibb in Cambridge, Massachusetts. Her role involves contributing to the company's research and development initiatives. Having previously accumulated significant experience in early target biology, Christine now brings her expertise to further the company's scientific endeavors.
Previous Roles at Bristol Myers Squibb
Prior to her current role, Christine Strand worked as a Senior Associate Scientist in Early Target Biology at Bristol Myers Squibb from 2021 to 2022. Before this, she held the position of Associate Scientist in Early Target Biology at the same company from 2019 to 2021. Through these roles, Christine developed a deep understanding and expertise in early-stage research critical to drug development.
Leadership Experience at TEDxCambridge
Christine Strand served as the Operations Director at TEDxCambridge from 2019 to 2020. In this leadership role, she managed event logistics and operations. Her responsibilities included coordinating with speakers, overseeing event planning, and ensuring smooth execution of events, demonstrating her ability to lead and manage large-scale logistical efforts.
Research Contributions at the Broad Institute
Christine Strand contributed to research in genetic perturbation and functional genomics during her tenure as a Research Associate II at the Broad Institute of MIT and Harvard from 2016 to 2019. Her work at the Broad Institute was integral to advancing understanding in functional genomics, providing significant insights into gene functions and their implications in various biological processes.
Educational Background in Biochemistry
Christine Strand studied Biochemistry at the University of Wisconsin-Madison, earning a Bachelor of Science (BSc) degree from 2011 to 2015. This academic foundation laid the groundwork for her subsequent career in scientific research and development, equipping her with the knowledge and skills necessary for her roles in the biotech and pharmaceutical industries.